or Try an Advanced Search...

    Endocrine Disorders Stocks List

    Symbol Grade Name % Change
    PFE F Pfizer, Inc. -0.13
    VKTX F Viking Therapeutics, Inc. 0.19
    ENZ F Enzo Biochem, Inc. -1.73
    SPRB F Spruce Biosciences, Inc. -0.49
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
    Related Stock Lists: Biopharmaceutical Cancer Diabetes Disease Medication Medicine Metabolic Disease Obesity Acid Alcohol Alzheimer's Disease Anemia Animal Health Anti Infectives Antibodies Autoimmune Disease Biochemistry Biology Biotechnology Cachexia

    Related ETFs - A few ETFs which own one or more of the above listed Endocrine Disorders stocks.

    Symbol Grade Name Weight
    HDLB B ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 13.4
    THNR F Amplify Weight Loss Drug & Treatment ETF 7.61
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 7.25
    OZEM F Roundhill GLP-1 & Weight Loss ETF 6.46
    FDL A First Trust Morningstar ETF 5.94
    View all Endocrine Disorders ETFs...
    Compare ETFs
    Compare HDLB to THNR Compare OZEM to FDL Compare THNR to FDL

        Endocrine Disorders Stocks Recent News

        Date Stock Title
        Nov 21 PFE Optimism over global healthcare sector rises: Jefferies
        Nov 21 PFE Major companies that are also popular short-selling stocks
        Nov 21 PFE 5 Best Value Stocks With Discounted PEG to Boost Your Portfolio Return
        Nov 21 PFE The Zacks Analyst Blog Highlights Adobe, Pfizer, Dollar General, Snap and Ryanair
        Nov 21 PFE Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU
        Nov 21 PFE 2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist
        Nov 21 PFE EC marketing authorisation granted to Pfizer’s HYMPAVZI for haemophilia
        Nov 21 PFE 2 Dividend Stocks That Pay More Than 6% That Retirees Can Safely Buy and Hold for Years
        Nov 20 PFE CDC warns of an imminent spike in COVID, flu cases
        Nov 20 PFE 5 Year-to-Date Laggards to Buy Amid Solid Near-Term Upside Potential
        Nov 20 VKTX Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs
        Nov 20 PFE Pfizer Appoints Cancer Research Head Chris Boshoff as New R&D Chief
        Nov 20 PFE Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan
        Nov 20 PFE Pfizer names head of oncology as new R&D chief
        Nov 20 PFE Pfizer Announces New Chief Scientific Officer and President, Research & Development
        Nov 20 PFE Pfizer names oncology head Chris Boshoff as R&D chief
        Nov 20 PFE Pfizer Names New R&D Chief
        Nov 20 PFE Pfizer, under pressure to change, names oncology head as new R&D chief
        Nov 20 PFE Is It Time to Sell Eli Lilly and Pfizer Stocks?
        Nov 20 PFE European Commission Approves Pfizer’s HYMPAVZI™ (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
        Related Stock Lists: Biopharmaceutical Cancer Diabetes Disease Medication Medicine Metabolic Disease Obesity Acid Alcohol Alzheimer's Disease Anemia Animal Health Anti Infectives Antibodies Autoimmune Disease Biochemistry Biology Biotechnology Cachexia
        Endocrine Disorders

        Endocrine disorders are medical conditions that affect the endocrine system, which is a network of glands that produce hormones that regulate many bodily functions, including metabolism, growth and development, and sexual function. Common endocrine disorders include diabetes, thyroid disease, and adrenal gland disorders.

        Browse All Tags